Trials / Completed
CompletedNCT00714740
Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the effect of acetazolamide as a treatment for sleep related breathing disturbances in patients with the obstructive sleep apnea syndrome living at low altitude during a sojourn at moderate altitude
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | acetazolamide | acetazolamide 2 times 250mg per day |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2008-07-14
- Last updated
- 2014-05-20
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00714740. Inclusion in this directory is not an endorsement.